Vimarsana
Biggest News Aggregation in the World

Page 36 - Hematologic Malignancies News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Hematologic Malignancies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Hematologic Malignancies Today - Breaking & Trending Today

Hematologic Malignancies Market size was estimated at $42.4 billion, projected to grow at a CAGR of 10.2% - IndustryARC - Vimarsana News

Hematologic Malignancies Market size was estimated at $42.4 billion, projected to grow at a CAGR of 10.2% - IndustryARC

Hematologic Malignancies Market size was estimated at $42.4 billion in 2020, projected to grow at a CAGR of 10.2% during the forecast period 2021-2026.

FDA Panel Finds Duvelisib Risks Outweigh Benefits in CLL/SLL - Vimarsana News

FDA Panel Finds Duvelisib Risks Outweigh Benefits in CLL/SLL

An expert panel questioned the value of the FDA-approved drug following 5-year follow-up data that showed a possible increased risk of death among patients with relapsed or refractory CLL/SLL.

Noted Oncologist Ponders Death, Life, Care Inequities - Vimarsana News

Noted Oncologist Ponders Death, Life, Care Inequities

A former news photographer in his native India, Kashyap Patel, MD, now runs his own oncology practice and is dedicated to eliminating disparities in US cancer care.

Cancer Moonshot Turns Focus to Early-Detection Blood Tests - Vimarsana News

Cancer Moonshot Turns Focus to Early-Detection Blood Tests

But if these tests are used more widely, oncologists will need to navigate a slew of new challenges.

Some Headway in Efforts to Make Clinical Trials More Inclusive - Vimarsana News

Some Headway in Efforts to Make Clinical Trials More Inclusive

For results from clinical trials to be more generalizable, there needs to be some loosening of exclusion criteria, say researchers who report that some headway has been made.